These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1551275)

  • 21. Cryptogenic hepatitis: a case study in autoantibody negative autoimmune hepatitis.
    Gacad V; Waller K
    Clin Lab Sci; 2011; 24(4):196-201. PubMed ID: 22288215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of intravenous immunoglobulin therapy in giant cell hepatitis with autoimmune hemolytic anemia: A multicenter study.
    Marsalli G; Nastasio S; Sciveres M; Calvo PL; Ramenghi U; Gatti S; Albano V; Lega S; Ventura A; Maggiore G
    Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):83-9. PubMed ID: 26138133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting.
    Neuberger J; Portmann B; Calne R; Williams R
    Transplantation; 1984 Apr; 37(4):363-5. PubMed ID: 6369666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.
    Sami N; Letko E; Androudi S; Daoud Y; Foster CS; Ahmed AR
    Ophthalmology; 2004 Jul; 111(7):1380-2. PubMed ID: 15234140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
    Jordan SC; Toyoda M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases.
    Blank M; Bashi T; Shoenfeld Y
    Methods Mol Biol; 2014; 1060():353-61. PubMed ID: 24037850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Humoral and cell-mediated immunity in the comparison of autologous hepatocytes in chronic active viral and autoimmune hepatitis].
    Mazzetti M; Zunarelli P; Cicognani G; Tisselli N; Pignatelli M; Baldini R; Pirillo L; Stefanini GF
    G Clin Med; 1982 Oct; 63(10):678-87. PubMed ID: 6985033
    [No Abstract]   [Full Text] [Related]  

  • 28. The detection of IgG anti-hepatocyte antibodies by ELISA in sera of patients with chronic active hepatitis: correlation with disease activity.
    Wood LJ; Saar N; Searle J; Halliday JW; Powell LW
    J Clin Lab Immunol; 1985 Aug; 17(4):167-71. PubMed ID: 4068030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical use of intravenous immunoglobulin IgG].
    Permin H; Herlin T; Koch HG; Pedersen FK
    Ugeskr Laeger; 1992 Nov; 154(48):3411-6. PubMed ID: 1334293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The enhancement of treatment efficacy in chronic liver failure by using hemoperfusion across donor hepatocytes and spleen fragments].
    Onishchenko NA; Bazieva FKh; Orzhekhovskaia IG; Toshchakov VIu; Polosina OV; Danilov MA; Suskova VS
    Ter Arkh; 1995; 67(2):6-9. PubMed ID: 7725264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic intravenous immunoglobulins.
    Lemieux R; Bazin R; Néron S
    Mol Immunol; 2005 May; 42(7):839-48. PubMed ID: 15829272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin therapy for autoimmune neutropenia in Hodgkin's disease.
    Schoengen A; Fembacher PM; Schulz PC
    Acta Haematol; 1995; 94(1):36-8. PubMed ID: 7653210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.
    Van Thiel DH; Molloy PJ; Friedlander L; Kania RJ; Fagiuoli S; Caraceni P; Wright HI; Zuhdi N
    Hepatogastroenterology; 1995; 42(6):900-6. PubMed ID: 8847043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulin G in the treatment of autoimmune bullous disease.
    Czernik A
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):118-9. PubMed ID: 25546786
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
    Mouthon L; Kaveri S; Kazatchkine M
    Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
    Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
    Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
    Francioni C; Fioravanti A; Gelli R; Megale F; Marcolongo R
    Recenti Prog Med; 1993 Oct; 84(10):679-86. PubMed ID: 8235034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.